RBD Fusion Dimer Vaccine (recombinant protein)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RBD Fusion Dimer Vaccine (recombinant protein), covering 2024-02-26 to 2024-02-26. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Immunogenicity of Recombinant Protein RBD Fusion Dimer Vaccine Against the Virus That Cause COVID-19, Known as Severe Acute Respiratoy Syndrome Coronavirus 2 (SARS-CoV-2) [Phase 2]